Afleveringen
-
This is the latest episode of the free DDW narrated podcast, titled âInnovation enabled by new drug discovery technologiesâ, which covers two articles written for DDW Volume 24 â Issue 3, Summer 2023. They are called: âCRISPR breakthroughs: New solutions for common diseasesâ and âRe-assessing the risks of drug-induced arrhythmias during drug discoveryâ.
In the first article, Rolf Turk, Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies.
In the second article, Dr Mark Treherne, Dr Jack Scannell and Dr Richard Saumarez answer the question: Can potentially lethal arrhythmias induced by novel drugs be better predicted by using more relevant and sophisticated electrophysiological screening methods?
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week the DDW news round-up takes a look at developments in cancer research, including AZâs acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
Zijn er afleveringen die ontbreken?
-
This is the latest episode of the free DDW narrated podcast, titled âCritical tools that support drug discovery and developmentâ, which covers two articles written for DDW Volume 24 â Issue 3, Summer 2023. They are called: âYou think you need an ELN⊠but are you asking the right questions?â and âBig data: Charting a new path to drug discovery and developmentâ.
In the first article, Matt Clifford, Director of Research and Innovation Strategy at IDBS, discusses the questions that need to be asked if youâre considering an ELN.
In the second article, Tim Lowery, President of JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied, or the unique methods employed in the trial.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âThe revolutionary impact of understanding genomicsâ, which covers two articles written for DDW Volume 24 â Issue 3, Summer 2023. They are called: âOpen science, genomics, and the quiet revolution in our approach to pharmaâ and âJunk DNA: How the dark genome is changing RNA therapiesâ.
In the first article, Evan Floden, CEO of Seqera Labs, examines how data sharing platforms are impacting cancer and genomics research.
In the second article, Samir Ounzain, CEO & Co-Founder of HAYA Therapeutics, looks at how a better understanding of our DNA can lead to increased activity for RNA therapeutics.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Our news round-up this week focuses on start-ups, the innovative fledgling companies that are coming through and sparking new life into various areas of drug discovery.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âWhere are the global epicentres of drug discovery innovation?â, which covers two articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the US? and Global start-ups: where is the innovation?
In the first article, I take a snapshot of the US biotech market and some of the ongoing research coming out of the US.
In the second, DDW editors take a look at some key global activity taking place around the world for drug discovery and life sciences start-ups.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Itâs been a mixed bag of news for gene therapies this week, ranging from huge successes in treating sight impairment, cystic fibrosis and hearing loss, to the quick sale of a previously successful gene therapy developer.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Following the news of cuts to medical research funding from the National Institutes of Health (NIH), this week we focus on some positive drug discovery news from North America, including FDA priority review for a number of innovative therapeutics and a new US centre for rare disease research.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
In this podcast we speak to experts from Lonza and Oxford Nanopore about their collaboration to bring direct mRNA sequencing (including N1-Methyl-pseudouridine) to a regulated environment and establish the new gold standard in sequencing technology.
We discuss how nanopore sequencing will be used to perform unbiased identity testing while enabling the simultaneous analyses of multiple critical quality attributes such as integrity (mRNA length and poly-A tail length) and capping.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Love is in their air this Valentineâs Day as this weekâs news round-up celebrates the importance of collaboration in life sciences, whether thatâs in the sharing of data, technology, or expertise.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âThe continued evidence of AIâs drug discovery valueâ, which covers two articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: âHow generative AI could improve drug discoveryâ and âCan artificial intelligence help craft new medicines?â
Absci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly. In the first article, DDW Editor Reece Armstrong speaks to Sean McClain, the Founder and CEO of Absci about how generative AI is being used within drug discovery and the companyâs work in the antibodies sector.
In the second article, Professor Sonika Bhatnagar explores how artificial intelligence is enabling drug discovery at rates never seen before.
-
The latest episode of the DDW Highlights podcast is now available. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Following World Cancer Day on 4 February, the news round-up this week focuses on new approaches to the treatment of cancer, including radiopharmaceuticals, programmable cell depletion and preventative vaccines.
You can listen here, or find The Drug Discovery World Podcast on Spotify or Google Play.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
In the same week that Phesi revealed that breast cancer is the most studied disease for the fourth year in a row, we have seen a number of breakthroughs in the treatment of solid tumours, both in the early preclinical and later clinical stages of research.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week we have seen a number of positive announcements related to the early clinical and preclinical development of immunotherapies, including an islet cell therapy for diabetes, an antibody-drug conjugate and a CAR-T therapy for multiple myeloma, and a peptide-drug conjugate and a vaccine for head and neck cancers.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Our news round-up at the end of last year focused on drug discovery investment, so it is positive to see that this has also started strong in 2025, with a number of new acquisitions, research partnership agreements and financings to kick off the new year.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âWhere are the global breakthroughs, opportunities and developments in cancer research?â, which covers three articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: âGlobal breakthroughs in cancer drug discoveryâ, âThe Achillesâ heel of cancerâ, and âImmunotherapy is here to stayâ.
At the time of writing in the first article, AstraZeneca UK had appointed David Brocklehurst as Head of Oncology in the UK. I spoke with him about how AstraZeneca is innovating to displace chemotherapy and research areas of significance.
In the second article, Genoscience Pharmaâs Philippe Halfon and Eric Raymond share their expertise on targeting the recycling of unsustainable production of palmitoylated cancer-associated proteins.
In the third article, I spoke with Frédéric Triebel, the French immunologist/oncologist who is best known for his 1990 discovery of the LAG-3 immune control mechanism. Triebel shares insights from his career, expands on his experience with the company he founded, Immutep, and comments on the future of immuno-oncology.
-
This is the latest episode of the free DDW narrated podcast, titled âInnovative approaches to improving drug discoveryâ, which covers three articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitting Down With Dr Harren Jhoti, Astex Pharmaceuticals, and The Nobel Prize winning power of click chemistry.
In the first article, Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne, and Dr Jenny Barnett explore the effects of long Covid symptoms and what the opportunities are for drug developers working to treat post-Covid cognitive impairment.
In the second article, Dr Harren Jhoti speaks to Diana Spencer after receiving his OBE, about his career, the UK life sciences sector, fragment-based drug discovery and what the future holds for the industry.
In the third article, JosĂ© MejĂa Oneto, PhD, Founder and CEO at Shasqi, discusses the potential of chemistry to engineer biology to improve the effectiveness of human therapeutics and revolutionise the treatment of disease.
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
As we approach the end of 2024, itâs great to see that investment in drug discovery is still going strong, with an impressive $300 million raised by AI-focused company SandboxAQ and another significant financing by Ottimo Pharma.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Itâs been a big week for cell and gene therapies (CGTs) as the first in vivo BCMA CAR-T candidate reaches the clinic and a new discovery could lead to a gene therapy that reverses a significant cause of stillbirth and premature delivery.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
- Laat meer zien
